-
Atosiban for threatened preterm birth: the APOSTEL 8 trial – Authors' reply
van der Windt, L. I. & Oudijk, M. A., 27 Sept 2025, In: The Lancet. 406, 10510, p. 1339-1340 2 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
High intelligence and intelligence profile discrepancies in preterm children: a systematic review and meta-analysis
van der Windt, L. I., Schrijver, Y. N., Denswil, N. P., Leemhuis, A. G., van Wely, M., Pajkrt, E., Aarnoudse-Moens, C. S. H. & van 't Hooft, J., 1 Sept 2025, In: Acta psychologica. 259, p. 105239 105239.Research output: Contribution to journal › Review article › Academic › peer-review
-
Atosiban versus placebo for threatened preterm birth (APOSTEL 8): a multicentre, randomised controlled trial
APOSTEL 8 Study Group, 22 Mar 2025, In: Lancet. 405, 10483, p. 1004-1013 10 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications